Therapeutic potential for KCC2-targeted neurological diseases

• मुख्य लेखकों: Kazuo Tomita (लेखक), Yoshikazu Kuwahara (लेखक), Kento Igarashi (लेखक), Junichi Kitanaka (लेखक), Nobue Kitanaka (लेखक), Yuko Takashi (लेखक), Koh-ichi Tanaka (लेखक), Mehryar Habibi Roudkenar (लेखक), Amaneh Mohammadi Roushandeh (लेखक), Akihiro Kurimasa (लेखक), Yoshihiro Nishitani (लेखक), Tomoaki Sato (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2023-12-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Patients with neurological diseases, such as schizophrenia, tend to show low K+-Cl- co-transporter 2 (KCC2) levels in the brain. The cause of these diseases has been associated with stress and neuroinflammation. However, since the pathogenesis of these diseases is not yet fully investigated, drug th...